Standardized patient coaching improves therapy persistence in patients with hormone receptor–positive, HER2–negative advanced/metastatic breast cancer treated with abemaciclib
Individual patient coaching based on MOATT© demonstrated improved PR24 for patients undergoing abemaciclib treatment for aBC.
Authors
- B. Lex
- D Langanke
- Christoph Uleer (ORCID: https://orcid.org/0000-0002-7937-8182)
- Tobias Hesse
- Erik Belleville
- Sabrina Uhrig
- Lorenz Rieger
- N. Deuerling
- Lothar Mueller
- Nicole Semmler-Lins
- Mark-Oliver Zahn
- Hans Tesch
- Peter A. Fasching
- Manfred Welslau
- Lothar Häberle
Institutions
- University of Hildesheim (DE)
- Universitätsklinikum Erlangen (DE)
- Cardiovascular Center Bethanien (DE)
- Pain and Headache Center (US)
- St. Elisabeth-Krankenhaus Leipzig (DE)
- Klinikum Aschaffenburg (DE)
- University of Applied Sciences Emden Leer (DE)
- Klinikum Weiden (DE)
- Agaplesion Diakonieklinikum Rotenburg (DE)
- Sasol (Germany) (DE)
Publication Details
- Journal
- The Breast
- Published
- 2025-12-24
- DOI
- https://doi.org/10.1016/j.breast.2025.104684
- Primary Topic
- Advanced Breast Cancer Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company